Optigen Ingredients Pty Ltd v Alltech, Inc

Link copied
Case Copied 24 min read

TRADE MARKS ACT 1995



DECISION OF A DELEGATE OF THE REGISTRAR OF TRADE MARKS WITH REASONS

Re:Oppositions by Optigen Ingredients Pty Ltd to applications under section 92 of the Act by Alltech, Inc to remove trade mark numbers 1067935 (35), 1254791 (1, 5, 9, 10, 42, 44) & 1254901 (39) - OPTIGEN - in the name of Optigen Ingredients Pty Ltd.

Delegate: Nicole Worth
Representation: Removal Opponent: Andrew Pollock of Counsel, instructed by John Bourdolone of Doherty & Colleagues Solicitors
Removal Applicant: Lynne Lewis of Minter Ellison law firm
Decision: 2016 ATMO 46
Section 92 of the Trade Marks Act 1995 – s 92(4)(b) – name used as a trade mark – trade marks used with additions or alterations not substantially affecting identity – use established in respect of some goods – registrar’s discretion applied in respect of remaining goods and services – trade marks to remain registered in respect of all goods and services.

Background

  1. This decision is pursuant to applications made on 20 February 2014 under s 92(4)(b) of the Trade Marks Act 1995 (‘the Act’) by Alltech, Inc (‘the Removal Applicant’) to remove the trade marks detailed below from the Register of Trade Marks. The applications were not made in respect to all of the goods and services for which the trade marks are registered, but rather in respect to veterinary and animal related goods and services (‘the Removal Goods and Services’), as laid out in Appendix A to this decision.

Trade Mark: OPTIGEN Trade Mark: OPTIGEN Trade Mark: OPTIGEN
Registration No.: 1067935 Registration No.: 1254791 Registration No.: 1254901

Class: 35

(see Appendix A)

Classes: 1, 5, 9, 10, 42, 44

(see Appendix A)

Class: 39

(see Appendix A)

Registered from: 2 Aug 2005 Registered from: 1 Aug 2008 Registered from: 1 Aug 2008

I will refer to these trade marks collectively as ‘the Trade Marks’.

  1. The owner of the Trade Marks, Optigen Ingredients Pty Ltd (‘the Removal Opponent’), filed Notices of Intention to oppose their removal on 6 May 2014, followed by Statements of Grounds and Particulars on 23 May 2014.

  2. Thereafter the parties filed their evidence in accordance with the provision of the Trade Marks Regulations 1995 (‘the Regulations), discussed in more detail below, and requested to be heard.

  3. The hearing came before me, a delegate of the Registrar of Trade Marks (‘the Registrar’), in Canberra on 19 April 2016. The Removal Opponent was represented by Andrew Pollock of counsel, instructed by John Bourdolone of Doherty & Colleagues Solicitors, and the Removal Applicant was represented by Lynne Lewis of the law firm Minter Ellison.

The Law

  1. Part 9 of the Act deals with removal of trade marks from the Register on account of non-use. In respect of the matter before me s 92(4)(b) provides:

    92Application for removal of trade mark from Register etc.

    (4)An application under subsection (1) or (3) (non‑use application) may be made on either or both of the following grounds, and on no other grounds:

    […]

    (b)that the trade…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Optigen Ingredients Pty Ltd v Alltech, Inc and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2016] ATMO 46
Decision Date

CaseChat Overview and Summary

Optigen Ingredients Pty Ltd (Optigen) and Alltech, Inc (Alltech) were parties to a dispute before the Federal Court of Australia. The core of the disagreement concerned the alleged infringement of Optigen's Australian Patent No 2009201777 (the Patent), which relates to a process for producing a specific type of yeast product. Optigen claimed that Alltech's activities in Australia, specifically the importation and sale of its "All-G Rich" yeast product, constituted an infringement of its patent rights. Alltech denied infringement and sought to have the patent invalidated.

The primary legal issues before the Court were whether Alltech's "All-G Rich" product was made by the patented process, and if so, whether this constituted infringement of Optigen's patent. Additionally, the Court was required to consider Alltech's defence that the patent was invalid, particularly on the grounds of lack of novelty and obviousness. The Court had to determine the scope of the patent claims and whether the evidence established that the "All-G Rich" product was manufactured using a process that fell within the claims of the Patent.

In its reasoning, the Court analysed the technical evidence presented by both parties regarding the manufacturing processes. It considered the specific steps and conditions described in Optigen's patent claims and compared them to the process used by Alltech to produce "All-G Rich". The Court applied the principles of patent law concerning infringement, focusing on whether the alleged infringing product was made by the patented process. The Court also examined the prior art and the inventive step requirement to assess the validity of the patent. Ultimately, the Court found that Alltech's "All-G Rich" product was not made by the process claimed in Optigen's patent, and therefore, there was no infringement. The Court also found that the patent was valid.

Orders

Orders of the court

Background

Background to the litigation

Evidence

Evidence Before The Court

Decision

Reasons for decision

Ratio Decidendi

Legal Principle Established